Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)


This company has been moved to the archive! The financial data has not been updated since February 15, 2024.

Analysis of Debt

Microsoft Excel

Paying users area

The data is hidden behind: . Unhide it.

  • Get 1-month access to Vertex Pharmaceuticals Inc. for $22.49, or

  • get full access to the entire website for at least 3 months from $62.19.

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Total Debt (Carrying Amount)

Vertex Pharmaceuticals Inc., balance sheet: debt

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Current finance lease liabilities
Long-term finance lease liabilities
Total finance lease liabilities (carrying amount)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Debt item Description The company
Total finance lease liabilities (carrying amount) Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. Vertex Pharmaceuticals Inc. total debt decreased from 2021 to 2022 and from 2022 to 2023.

Total Debt (Fair Value)

Microsoft Excel
Dec 31, 2023
Selected Financial Data (US$ in thousands)
Total finance lease liabilities (fair value)
Financial Ratio
Debt, fair value to carrying amount ratio

Based on: 10-K (reporting date: 2023-12-31).

Weighted-average Interest Rate on Debt

Weighted-average discount rate, finance leases:

Interest rate Debt amount1 Interest rate × Debt amount Weighted-average interest rate2

Based on: 10-K (reporting date: 2023-12-31).

1 US$ in thousands

2 Weighted-average interest rate = 100 × ÷ =